Health Care: Drugs

Geron Corp (GERN: NASDAQ)

$2.16 0.01 | 0.47%
09/23/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.28M 2.71M 2.44M 3.56M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 1.28M 2.71M 2.44M 3.56M
Selling, General, and Administrative Expenses 15.62M 20.40M 23.79M 18.04M
Research & Development 23.16M 51.37M 69.32M 61.69M
Operating Income before D & A (EBITDA) -37.50M -69.06M -90.67M -76.17M
Depreciation & Amortization 2.10M 3.74M 6.76M 5.82M
Interest Income 951.00K 3.10M 1.02M 2.04M
Other Income - Net -316.00K 13.00K -1.02M 190.00K
Special Income / Charges 0.00 0.00 0.00 -70.00M
Total Income Before Interest Expenses (EBIT) -40.42M -72.39M -103.38M -117.10M
Interest Expense 56.00K 233.00K 237.00K 98.00K
Pre-Tax Income -40.48M -72.62M -103.62M -117.20M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -38.38M -68.88M -96.85M -111.38M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -38.38M -68.88M -96.85M -111.38M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -38.38M -68.88M -96.85M -111.38M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-36.92M -66.18M -91.40M -76.38M
Preferred Dividends
Net Income Available To Common -38.38M -68.88M -96.85M -111.38M
Basic EPS from Continuing Ops. -0.30 -0.54 -0.78 -1.14
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.30 -0.54 -0.78 -1.14
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.30 -0.54 -0.78 -1.14
Basic Normalized Net Income/Share -0.29 -0.52 -0.73 -0.78
EPS fr Continuing Ops. -0.30 -0.54 -0.78 -1.14
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.30 -0.54 -0.78 -1.14
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.30 -0.54 -0.78 -1.14
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.29 -0.52 -0.73 -0.78
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GERN

Latest GERN Headlines from TheStreet

More Financial News for GERN

Press Releases for GERN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter